Status:
COMPLETED
Analysis of Atropine and Propranolol Induced Changes
Lead Sponsor:
National Institute on Aging (NIA)
Conditions:
Healthy
Eligibility:
All Genders
21-40 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to learn the effects of genetic make up on response to the drugs atropine and propranolol, to examine how changes in heart rate and blood pressure can be measured, and to ...
Detailed Description
Healthy volunteers will be recruited and screened for eligibility. Participants will be placed into three possible groups based on genetic information obtained during screening. Rolling admissions wil...
Eligibility Criteria
Inclusion
- Healthy male and female volunteers
- Ages 21-40
- Body Mass Index \>18.0 and \<27.0
Exclusion
- History of any chronic illnesses including cardiac diseases and bleeding problems
- Drug use of any kind
- Participation in any clinical trial within the last month
- Tobacco use and/or alcohol abuse
- Use of dietary supplements and unwillingness to refrain
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00251602
Start Date
March 1 2003
End Date
August 1 2012
Last Update
August 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute on Aging, Harbor Hospital
Baltimore, Maryland, United States, 21225